Teneligliptin Hydrobromide Intermediate CAS 401564-36-1 Purity >99.5% (HPLC) Factory

Name: Teneligliptin Hydrobromide Intermediate CAS: 401564-36-1 Enantiomeric Purity: >99.5% (By HPLC) Assay: 99.5~102.0% (On Dried Basis) Appearance: White to Cream Coloured Solid Intermediate of Teneligliptin HBr (CAS: 906093-29-6) E-Mail: alvin@ruifuchem.com

Products Details

Chemical Properties:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moistureSupply Teneligliptin Hydrobromide Related Intermediates With High Purity Teneligliptin Hydrobromide CAS 906093-29-6 1-(3-Methyl-1-Phenyl-5-Pyrazolyl)piperazine CAS 401566-79-8 Teneligliptin Hydrobromide Intermediate CAS 401564-36-1
Item Inspection Standard Results
Appearance White to Cream Coloured Solid Conform
Identification IR; HPLC RT Conform
Loss on Drying <1.00% 0.20%
Related Substances Any Single Impurity <0.50% 0.24%
Total Impurity <0.50% 0.39%
Assay 99.5%~102.0% (On Dried Basis) 99.8%
Enantiomeric Purity >99.5% 99.9%
Sulphated Ash <0.20% 0.02%
Test Standard Enterprise Standard
Usage Intermediates of Teneligliptin Hydrobromide (CAS: 906093-29-6)

Description:

Specifications:

Package & Storage:

Chemical Name (2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester
Synonyms (S)-tert-Butyl 4-oxo-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate; 3-((S)-1-tert-butoxycarbonyl-4-oxo-2-pyrrolidinylcarbonyl)-1,3-thiazolidine; (2S)-4-oxo-2-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidine-1-carboxylate; Teneligptin Intermediate B
CAS Number 401564-36-1
CAT Number RF-1818
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C13H20N2O4S
Molecular Weight 300.37
Density 1.305
Brand Ruifu Chemical

Advantages:

FAQ:

Application:

(2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester (CAS: 401564-36-1) is an intermediate used to prepare dipeptidyl peptidase IV (DPP-IV) inhibitor, intermediates of Teneligliptin Hydrobromide (CAS: 906093-29-6). Teneligliptin is a DPP-4 inhibitor which was approved in Japan in 2012 for the treatment of type II diabetes. It was discovered and developed by Mitsubishi Tanabe Pharma under the trade name Tenelia®. Similar to other marketed DPP-4 inhibitors, Teneligliptin was well tolerated in all studies and QD dosing produced a long-lasting inhibitory action against DPP-4 and an increase in active GLP-1 levels, with very low rates of renal excretion.

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours